Director
DIN: 07425644
Hitesh Chandrakant Bari is currently associated with 3 companies in various capacities such as Director, Individual Promoter and Designated Partner. They serve as a Director at UNIGRACE PHARMACEUTICALS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 07425644.Hitesh Chandrakant Bari is currently involved in 3 different roles. Their most recent position is with EBIS PHARMA PRIVATE LIMITED as a Director. The first company Hitesh Chandrakant Bari was appointed to as a director was UNIGRACE PHARMACEUTICALS PRIVATE LIMITED. Hitesh Chandrakant Bari is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Hitesh Chandrakant Bari is currently associated with 3 companies in various capacities such as Director, Individual Promoter and Designated Partner. They serve as a Director at UNIGRACE PHARMACEUTICALS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 07425644.Hitesh Chandrakant Bari is currently involved in 3 different roles. Their most recent position is with EBIS PHARMA PRIVATE LIMITED as a Director. The first company Hitesh Chandrakant Bari was appointed to as a director was UNIGRACE PHARMACEUTICALS PRIVATE LIMITED. Hitesh Chandrakant Bari is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
4
Male
India
Call +91 81049 46419 and we'll pull the verified contact details for you.
Current Companies (2)
Current LLPs (1)
Past Companies (0)
2y 1m 1y 1m Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| UNIGRACE PHARMACEUTICALS PRIVATE LIMITED | Director | 13-Apr-2016 |
| UNIGRACE PHARMACEUTICALS PRIVATE LIMITED | Individual Promoter | 13-Apr-2016 |
| EBIS PHARMA PRIVATE LIMITED | Director | 12-May-2026 |